Stay updated on Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.

Latest updates to the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedResults have been posted for NCT04777331, including the Outcome Measures (Results). The Study Status has been updated, and the page now displays the results section alongside the existing study details.SummaryDifference0.4%

- Check15 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2; no changes to the study history content are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check22 days agoChange DetectedFooter revision tag updated from v3.2.0 to v3.3.1 on the Record History page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedNotice about government funding and potential updates delay was removed from the page. This may impact users' perception of data timeliness on the record history page.SummaryDifference0.4%

- Check37 days agoChange DetectedLatest history version introduces an administrative QC status note and adds new sections (Study Status, Contacts/Locations, Outcome Measures, and Outcome Measures (Results)) with date stamps of 2025-10-23 and 2025-11-05.SummaryDifference0.5%

- Check44 days agoChange DetectedA new version entry appears in the study record history, indicating updates to the history page. There is no indication of changes to the study's core content, eligibility criteria, or outcomes.SummaryDifference0.1%

Stay in the know with updates to Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.